Literature DB >> 22652628

Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway.

S Xu, H Evans, C Buckle, K De Veirman, J Hu, D Xu, E Menu, A De Becker, I Vande Broek, X Leleu, B V Camp, P Croucher, K Vanderkerken, I Van Riet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22652628     DOI： 10.1038/leu.2012.126

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  19 in total

Review 1.  MGUS to myeloma: a mysterious gammopathy of underexplored significance.

Authors:  Madhav V Dhodapkar
Journal:  Blood       Date:  2016-10-13       Impact factor: 22.113

Review 2.  Multiple myeloma mesenchymal stromal cells: Contribution to myeloma bone disease and therapeutics.

Authors:  Antonio Garcia-Gomez; Fermin Sanchez-Guijo; M Consuelo Del Cañizo; Jesus F San Miguel; Mercedes Garayoa
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

3.  Dkk-1 and IL-7 in plasma of patients with multiple myeloma prevent differentiation of mesenchymal stem cells into osteoblasts.

Authors:  Brittany A Nierste; Carlotta A Glackin; Julia Kirshner
Journal:  Am J Blood Res       Date:  2014-12-15

4.  Notch-Hes pathway mediates the impaired osteogenic differentiation of bone marrow mesenchymal stromal cells from myelodysplastic syndromes patients through the down-regulation of Runx2.

Authors:  Chengming Fei; Juan Guo; Youshan Zhao; Shucheng Gu; Sida Zhao; Xiao Li; Chunkang Chang
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

Review 5.  Multiple Myeloma: Molecular Pathogenesis and Disease Evolution.

Authors:  Michael Heider; Katharina Nickel; Marion Högner; Florian Bassermann
Journal:  Oncol Res Treat       Date:  2021-11-08       Impact factor: 2.825

6.  Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo.

Authors:  Song Xu; Kim De Veirman; Holly Evans; Gaia Cecilia Santini; Isabelle Vande Broek; Xavier Leleu; Ann De Becker; Ben Van Camp; Peter Croucher; Karin Vanderkerken; Ivan Van Riet
Journal:  Acta Pharmacol Sin       Date:  2013-04-08       Impact factor: 6.150

7.  Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model.

Authors:  Michaela R Reagan; Yuji Mishima; Siobhan V Glavey; Yong Zhang; Salomon Manier; Zhi Ning Lu; Masoumeh Memarzadeh; Yu Zhang; Antonio Sacco; Yosra Aljawai; Jiantao Shi; Yu-Tzu Tai; John E Ready; David L Kaplan; Aldo M Roccaro; Irene M Ghobrial
Journal:  Blood       Date:  2014-09-09       Impact factor: 22.113

8.  K562 chronic myeloid leukemia cells modify osteogenic differentiation and gene expression of bone marrow stromal cells.

Authors:  Atul Kumar; Trishna Anand; Jina Bhattacharyya; Amit Sharma; Bithiah Grace Jaganathan
Journal:  J Cell Commun Signal       Date:  2017-09-30       Impact factor: 5.782

Review 9.  The roles of mesenchymal stem cells in tumor inflammatory microenvironment.

Authors:  Zhao Sun; Shihua Wang; Robert Chunhua Zhao
Journal:  J Hematol Oncol       Date:  2014-02-06       Impact factor: 17.388

10.  The osteoblastogenesis potential of adipose mesenchymal stem cells in myeloma patients who had received intensive therapy.

Authors:  Hsiu-Hsia Lin; Shiaw-Min Hwang; Shang-Ju Wu; Lee-Feng Hsu; Yi-Hua Liao; Yi-Shuan Sheen; Wen-Hui Chuang; Shang-Yi Huang
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.